Cetera Investment Advisers’s CervoMed CRVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.8K Sell
19,622
-7,715
-28% -$27.2K ﹤0.01% 4749
2026
Q1
$108K Hold
27,337
﹤0.01% 4431
2025
Q4
$216K Sell
27,337
-103
-0.4% -$828 ﹤0.01% 4183
2025
Q3
$222K Buy
+27,440
New +$235K ﹤0.01% 4084
2021
Q4
Sell
-204
Closed -$8K 1872
2021
Q3
$8K Buy
+204
New +$8.49K ﹤0.01% 1775

Other funds holding CRVO

Cetera Investment Advisers's CRVO Position: Q2 2026 in Review

Cetera Investment Advisers reduced its CervoMed (CRVO) stake by 28% in Q2 2026, selling an estimated $27.2K and leaving 19,622 shares worth $60.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4749.

Cetera Investment Advisers first reported a position in CRVO in Q3 2021 and has held it in 5 quarters since. The position peaked at $222K in Q3 2025. 37 funds tracked by Wall St. Rank hold CRVO as of Q2 2026.

  • Cetera Investment Advisers held 19,622 shares of CervoMed worth $60.8K as of Q2 2026.
  • Cetera Investment Advisers sold 7,715 CervoMed shares in Q2 2026, an estimated $27.2K.
  • CervoMed made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4749 holding.
  • Cetera Investment Advisers first reported a position in CervoMed in Q3 2021 and has held it in 5 quarters since.
  • Cetera Investment Advisers's CervoMed position peaked at $222K in Q3 2025.
  • 37 funds tracked by Wall St. Rank held CervoMed as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.